Upstate Active Clinical Trials
Study Title:PBD 01187: A Phase 2A Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Varoglutamstat (PQ912) in Patients with Early Alzheimer’s Disease with a Stage Gate to Phase 2B (VIVAMIND)
What is the purpose of the study?To evaluate the safety and efficacy of Varoglutamstat (PQ912) for early Alzheimer's disease
Upstate Institutional Review Board (IRB) Number:1759872
Study/Protocol ID:PBD 01187
Study Phase:Phase 2A-B
Patient Age Group:Adults
Principal Investigator:Sharon A Brangman
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
MRI, EEG, lumbar puncture
Where will the study take place?Clinical Research Unit (CRU)
Who can I contact for more information?
Name: Colleen A Dillenbeck